archive-nz.com » NZ » B » BBRAUN.CO.NZ

Total: 448

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • B. Braun Melsungen AG - Products - Ondansetron B. Braun 2 mg/ml
    relaxants Non Opioids Opioids Product QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Products IV Drugs Antiemetics Ondansetron B Braun 2 mg ml Ondansetron B Braun 2 mg ml Antiemetic Description Patients with nausea and vomiting induced by operations PONV chemotherapy CINV or radiotherapy RINV consume more resources and require more nursing time Limited resources require more to focus on antiemetic strategies An effective and economic therapy is available now with Ondansetron B Braun 2 mg ml Advantages Full indication for prophylaxis and treatment of PONV CINV and RINV No change required in user habits due to complete bioequivalence to originator drug Indication Adults Prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy Prevention and treatment of postoperative nausea and vomiting PONV Paediatric population Management of chemotherapy induced nausea and vomiting CINV in children aged 6 months Prevention and treatment of postoperative nausea and vomiting PONV in children aged 1 month Properties Mini Plasco connect container Integrated finger stopper prevents contamination of ampoule neck Drip fre and needle free withdrawal

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000203&prid=PRID00003254 (2016-05-02)
    Open archived version from archive


  • B. Braun Melsungen AG - Products - Granisetron B. Braun 1 mg/ml
    Career B Braun New Zealand Vacancies Product Overview IV Drugs IV Anesthetics Local Anesthetics Antiemetics Antidotes Antibiotics Antifungals Anticoagulants Muscle relaxants Non Opioids Opioids Product QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Products IV Drugs Antiemetics Granisetron B Braun 1 mg ml Granisetron B Braun 1 mg ml Antiemetic Description Patients with nausea and vomiting induced by operations PONV chemotherapy CINV or radiotherapy RINV consume more resources and require more nursing time Limited resources require more to focus on antiemetic strategies An effective and economic therapy is available now with Granisetron B Braun 1 mg ml Advantages Full indication for prophylaxis and treatment of PONV CINV and RINV No change required in user habits due to bioequivalence with originator drug Indication Prevention or treatment of Acute nausea and vomiting induced by chemotherapy and radiotherapy Post operative nausea and vomiting Prevention of Delayed nausea and vomiting associated chemotherapy and radiotherapy Children aged 2 years and above Prevention and treatment of acute nausea and vomiting associated with chemotherapy Properties Presentation 1 ml and 3 ml

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000203&prid=PRID00004611 (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Products - Flumazenil B. Braun 0.1 mg/ml
    Products IV Drugs Antidotes Flumazenil B Braun 0 1 mg ml Flumazenil B Braun 0 1 mg ml Competitive Benzodiazepine Antagonist Description Patients are unique in their physiologic conditions and may require counteractive measure to originally desired effects Reversal of effects of benzodiazepines may be needed in conscious sedation and general anesthesia or in the management of suspected or proven benzodiazepine overdose Flumazenil antagonizes sedation impairment of recall and life threatening complications produced by benzodiazepines The now available Flumazenil B Braun 0 1 mg ml can be used without change in user habits while keeping the budget in balance Advantages Antagonist for all benzodiazepines Onset of action within 1 2 minutes No change of user habits Indication Flumazenil is indicated in adults for the complete or partial reversal of the central sedative effects of benzodiazepines It may therefore be used in anaesthesia and in the intensive care in the following situations Anesthesia Termination of hypnosedative effects in general anesthesia which are induced and or maintained with benzodiazepines in hospitalized patients Reversal of benzodiazepine sedation in short term diagnostic and therapeutic procedures in ambulatory patients and hospitalized patients Intensive Care For the specific reversal of the central effects of benzodiazepines in

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000204&prid=PRID00003754 (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Products - Naloxone HCI B. Braun 0.4 mg/ml
    IV Drugs IV Anesthetics Local Anesthetics Antiemetics Antidotes Antibiotics Antifungals Anticoagulants Muscle relaxants Non Opioids Opioids Product QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Products IV Drugs Antidotes Naloxone HCI B Braun 0 4 mg ml Naloxone HCI B Braun 0 4 mg ml Specific Opioid Antagonist Description Naloxone B Braun 0 4 mg ml is a specific opioid antagonist for intravenous injection infusion and intramuscular application Suspected or proven acute opioid overdose or opioid induced postoperative adverse effects such as respiratory depression can lead to a life threatening situation for the patient Such side effects produced by opioids can be effectively antagonized with Naloxone B Braun 0 4 mg ml Advantages Antagonist for natural and synthetic opioids Complete or partial reversal of opioid effects No change of user habits For injection intravenous infusion and intramuscular application Indication Complete or partial reversal of CNS and especially respiratory depression caused by natural or synthetic opioids Diagnosis of suspected acute opioid overdosage Reversal of respiratory and other CNS depression in neonates whose mothers have received

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000204&prid=PRID00003755 (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Products - Metronidazole B. Braun
    QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Products IV Drugs Antibiotics Metronidazole B Braun Metronidazole B Braun Antibiotic Description For the treatment and prophylaxis of infections caused by metronidazole susceptible microorganisms mainly anaerobic bacteria Indication Infections of the central nervous system e g brain abscess meningitis Infections of the lung and pleura e g necrotising pneumonia aspiration pneumonia lung abscess Endocarditis Infections in the gastrointestinal tract and the abdominal area e g peritonitis liver abscess postoperative infections after colonic and rectal surgery purulent diseases in the abdominal and pelvic cavities Gynaecologic infections e g endometritis after hysterectomy or cesarean section childbed fever septic abortion Infections in the ear nose throat and tooth mouth jaw regions e g Plaut Vincent Angina Bone and joint infections e g osteomyelitis Gas gangrene Septicaemia with thrombophlebitis Properties Metronidazole B Braun 5 mg ml is available in state of the art Ecoflac plus containers for direct and easy infusion 500 mg 100 ml Reduced medication preparation steps and time Reduced risk of medication errors through higher accuracy of

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000205&prid=PRID00000123 (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Products - Gentamicin B. Braun
    Braun New Zealand Vacancies Product Overview IV Drugs IV Anesthetics Local Anesthetics Antiemetics Antidotes Antibiotics Antifungals Anticoagulants Muscle relaxants Non Opioids Opioids Product QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Products IV Drugs Antibiotics Gentamicin B Braun Gentamicin B Braun Antibiotic Description For the treatment of severe infections due to bacteria susceptible to gentamicin when less toxic antimicrobial agents are not effective Indication Complicated and recurrent urinary tract infections Nosocomial lower respiratory tract infections including severe pneumonia Intraabdominal infections including peritonitis Skin and soft tissue infections including severe burns Septicaemia including bacteraemia Treatment of bacterial endocarditis Treatment of surgical infections Properties Gentamicin B Braun is a pre mixed formulation ready for direct and convenient infusion The Ready to inf use solutions are available in Ecoflac plus container with a content of 80 mg 80 ml 1 mg ml 240 mg 80 ml 3 mg ml and 360 mg 120 ml 3 mg ml Reduced medication preparation steps and time Reduced risk of medication errors through higher accuracy of dosing Ecoflac plus provides excellent

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000205&prid=PRID00003975 (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Products - Tobramycin B. Braun
    Braun New Zealand Vacancies Product Overview IV Drugs IV Anesthetics Local Anesthetics Antiemetics Antidotes Antibiotics Antifungals Anticoagulants Muscle relaxants Non Opioids Opioids Product QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Products IV Drugs Antibiotics Tobramycin B Braun Tobramycin B Braun Antibiotic Description For the treatment of severe infections due to bacteria susceptible to tobramycin when less toxic antimicrobial agents are not effective Indication Nosocominal lower respiratory tract infections including severe pneumonia Exacerbation of lower respiratory tract infections in patients with cystic fibrosis Complicated and recurrent urinary tract infections Intra abdominal infections Skin and soft tissue infections including severe burns Properties Tobramycin B Braun is a pre mixed formulation ready for direct and convenient infusion The Ready to inf use solutions are available in Ecoflac plus container with a content of 80 mg 80 ml 1 mg ml 240 mg 80 ml 3 mg ml and 360 mg 120 ml 3 mg ml Reduced medication preparation steps and time Reduced risk of medication errors through higher accuracy of dosing Ecoflac plus provides excellent handling

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000205&prid=PRID00004550 (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Products - Amikacin B. Braun
    Amikacin B Braun Amikacin B Braun Antibiotic Description For the treatment of severe infections due to bacteria suscetible to amikacin when less toxic antimicrobial agents are not effective Indication Nosocomial lower respiratory tract infections including severe pneumonia Intra abdominal infections including peritonitis Complicated and recurrent urinary tract infections Skin and soft tissue infections including burn wound infections Bacterial endocarditis Post operative intra abdominal infections Properties Amikacin B Braun is a

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/products.html?id=00020744610000000205&prid=PRID00006502 (2016-05-02)
    Open archived version from archive